VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,810,453 | -10.2% | 104,439 | +0.5% | 0.37% | -7.0% |
| Q2 2023 | $3,128,640 | -5.8% | 103,907 | +1.2% | 0.40% | -11.7% |
| Q1 2023 | $3,322,960 | +12.5% | 102,719 | -0.3% | 0.45% | +10.2% |
| Q4 2022 | $2,953,900 | +11.7% | 103,067 | -6.0% | 0.41% | +2.2% |
| Q3 2022 | $2,645,000 | -20.9% | 109,641 | -10.2% | 0.40% | -22.3% |
| Q2 2022 | $3,343,000 | -27.7% | 122,084 | +1.3% | 0.52% | -18.2% |
| Q1 2022 | $4,622,000 | +19.7% | 120,527 | -0.0% | 0.63% | +17.7% |
| Q4 2021 | $3,861,000 | +9.0% | 120,547 | +0.3% | 0.54% | -0.9% |
| Q3 2021 | $3,543,000 | -11.8% | 120,234 | +1.7% | 0.54% | -10.6% |
| Q2 2021 | $4,016,000 | +9.1% | 118,194 | +4.4% | 0.60% | +1.5% |
| Q1 2021 | $3,681,000 | +4.3% | 113,254 | +15.6% | 0.60% | -9.6% |
| Q4 2020 | $3,530,000 | -28.7% | 98,012 | -22.5% | 0.66% | -36.0% |
| Q3 2020 | $4,953,000 | +25.1% | 126,488 | +17.2% | 1.03% | +17.7% |
| Q2 2020 | $3,958,000 | +73.5% | 107,899 | +9.0% | 0.87% | +45.4% |
| Q1 2020 | $2,281,000 | -21.6% | 99,016 | -0.4% | 0.60% | -0.5% |
| Q4 2019 | $2,910,000 | +9.8% | 99,388 | +0.1% | 0.60% | +3.1% |
| Q3 2019 | $2,651,000 | +3.0% | 99,249 | -1.4% | 0.59% | +1.2% |
| Q2 2019 | $2,574,000 | +10.9% | 100,702 | -2.7% | 0.58% | +4.9% |
| Q1 2019 | $2,320,000 | +5.4% | 103,496 | -0.9% | 0.55% | -7.7% |
| Q4 2018 | $2,202,000 | +12.9% | 104,432 | -0.8% | 0.60% | +34.4% |
| Q3 2018 | $1,951,000 | -13.3% | 105,322 | +4.5% | 0.44% | -21.1% |
| Q2 2018 | $2,249,000 | +7.8% | 100,788 | +6.1% | 0.56% | +0.9% |
| Q1 2018 | $2,087,000 | -4.6% | 94,962 | +0.9% | 0.56% | -5.3% |
| Q4 2017 | $2,188,000 | -7.1% | 94,138 | -8.2% | 0.59% | -11.9% |
| Q3 2017 | $2,354,000 | +4.0% | 102,540 | 0.0% | 0.67% | -11.7% |
| Q2 2017 | $2,264,000 | -3.3% | 102,540 | -0.1% | 0.76% | -9.6% |
| Q1 2017 | $2,341,000 | +8.2% | 102,638 | -0.7% | 0.84% | +1.9% |
| Q4 2016 | $2,163,000 | -19.2% | 103,375 | +2.1% | 0.82% | -23.4% |
| Q3 2016 | $2,677,000 | -4.2% | 101,269 | +0.4% | 1.08% | -7.1% |
| Q2 2016 | $2,795,000 | – | 100,873 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |